Brown-Forman Corporation (NYSE: BFA, BFB) reported financial results for its second quarter and first half of fiscal 2026, ended October 31, 2025. Second quarter reported net sales decreased 5% (1) to ...
Cheshire, UK – 28 April 2025 – BlackfinBio Ltd, a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases, announces today that the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback